Literature DB >> 31938411

Papillary thyroid carcinoma with nodular fasciitis-like stroma and β-catenin gene mutations: report of a recurrent case.

Liang Zhou1, Liuhong Shi1, Zhinong Jiang2, Lei Xie1.   

Abstract

Papillary thyroid carcinoma with nodular fasciitis-like stroma (PTC-NFS) is a rare lesion with dual pathological features, that behaves more aggressively if positive for β-catenin gene (CTNNB1) mutations. Recently, we encountered a recurrent PTC-NFS with CTNNB1 mutations. A 48-year-old female presented with a recurrent enlarging tumor with a diagnosis of desmoid-type fibromatosis 6 months after her initial operation for PTC-NFS. Over a 2-year observation period, she underwent remedial surgery to resect the recurrent tumor. During the operation, the left recurrent laryngeal nerve was engulfed and scarified. Local invasion, β-catenin aberrant staining, and CTNNB1 mutations were detected both in the primary tumor stroma and the recurrent tumor. This case indicates that CTNNB1 mutation screening and β-catenin staining should be performed in PTC-NFS cases as a predictor for recurrence. If either of these are positive, a wider surgical resection should be adopted to achieve negative margins. Otherwise, radiotherapy should be considered. Furthermore, the lesion might be better known as papillary thyroid carcinoma with desmoid-type fibromatosis in such situations to reflect its local aggressive nature. IJCEP
Copyright © 2018.

Entities:  

Keywords:  CTNNB1 mutations; Papillary thyroid carcinoma; desmoid tumor; desmoid-type fibromatosis; β-catenin aberrant staining

Year:  2018        PMID: 31938411      PMCID: PMC6958303     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  3 in total

1.  CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component.

Authors:  Abdallah Roukain; Gerasimos P Sykiotis
Journal:  Mod Pathol       Date:  2021-04-12       Impact factor: 7.842

2.  Papillary Thyroid Carcinoma with Nodular Fasciitis-Like Stroma in a 28-Year-Old Patient.

Authors:  Vahid Zand; Mansour Moghimi; Elmira Sadeghi; Pegah Kamal; Sedighe Vaziribozorg
Journal:  Iran J Pathol       Date:  2022-03-08

3.  Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases.

Authors:  David Suster; Michael Michal; Michiya Nishino; Simonetta Piana; Massimo Bongiovanni; Olga Blatnik; Veronika Hájková; Nikola Ptáková; Michal Michal; Saul Suster
Journal:  Mod Pathol       Date:  2020-04-14       Impact factor: 7.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.